| Code | Description | Claims | Beneficiaries | Total Paid |
|---|
| U0002 |
2019-ncov coronavirus, sars-cov-2/2019-ncov (covid-19), any technique, multiple types or subtypes (includes all targets), non-cdc |
12,936 |
6,104 |
$623K |
| 87426 |
|
11,693 |
5,927 |
$384K |
| G2023 |
Specimen collection for severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), any specimen source |
11,293 |
4,360 |
$230K |
| 99233 |
Prolong inpt eval add15 m |
2,164 |
288 |
$88K |
| 99211 |
|
5,108 |
2,777 |
$58K |
| C9803 |
Hospital outpatient clinic visit specimen collection for severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), any specimen source |
959 |
520 |
$19K |
| 99223 |
Prolong inpt eval add15 m |
130 |
125 |
$9K |
| 99000 |
|
1,288 |
613 |
$4K |
| 99358 |
Prolong nursin fac eval 15m |
88 |
88 |
$4K |
| P9603 |
Travel allowance one way in connection with medically necessary laboratory specimen collection drawn from home bound or nursing home bound patient; prorated miles actually travelled |
1,010 |
432 |
$4K |
| 87804 |
|
250 |
81 |
$2K |
| 87636 |
|
32 |
17 |
$2K |
| G2024 |
Specimen collection for severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]) from an individual in a snf or by a laboratory on behalf of a hha, any specimen source |
69 |
46 |
$1K |
| U0003 |
Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, making use of high throughput technologies as described by cms-2020-01-r |
61 |
13 |
$765.00 |
| 99406 |
|
35 |
35 |
$337.79 |
| 87635 |
|
28 |
13 |
$51.31 |